NY Times reports this story on the ‘Right to Try’ laws which allow critically ill patients the opportunity to try drugs not yet approved by the FDA. Unsurprisingly, the introduction of ‘Right to Try’ has sparked debate as critics say experimenting with unapproved drugs could cause more harm than good. Still, many patients with life-ending diagnoses want the option.
Startup Otonomy is among others including Pfizer, Novartis, and Roche who have heard and responded to the need for better treatment of ear conditions.
Groundbreaking new technology—an implant that attaches to the spine—may help paralyzed people walk again.
These are 10 affordable and cool products showcased at CES…I love #7.
Consumers are good. Mashable reports that Americans expect companies to incorporate social good and community service into their business models, and a staggering 90% say they are more likely to trust and stay loyal to a brand that tries to make a difference.
-Amanda Kopec Preto, Manager, Strategic Marketing & Corporate Communications